United States Drug Enforcement Administration

El Paso – Together with its law enforcement partners, the Drug Enforcement Administration will host its 26th National Prescription Drug Take Back Day on Saturday, April 27, from 10 a.m. to 2 p.m. This event aims to remove unneeded prescriptions from homes to help prevent medication misuse by offering anonymous...

The Drug Enforcement Administration’s Rocky Mountain Field Division (RMFD) is proud to be part of the 26th annual National Prescription Drug Take Back Day this Saturday, April 27, 2024 from 10:00am to 2:00pm MST at dozens of locations across Colorado, Utah, Wyoming and Montana. “DEA’s Take Back events serve as...

NEW HAVEN, Conn. - Vanessa Roberts Avery, United States Attorney for the District of Connecticut, and Stephen Belleau, Acting Special Agent in Charge of the Drug Enforcement Administration for New England, today announced that Cornerstone Pharmacy, Inc. (doing business as “Whalley Drug”), and its owner, YONG KWON, have entered into...

MILWAUKEE, Wis. - John McGarry, Assistant Special Agent in Charge of U.S. Drug Enforcement Administration-Milwaukee and Gregory J. Haanstad, United States Attorney for the Eastern District of Wisconsin, announced that on April 11, 2024, Herlin Hernandez-Trinidad, a/k/a “Rainely” (age: 29) of Miches, Dominican Republic, pled guilty to conspiring to possess...

NEWARK, N.J. – A pharmaceutical manufacturer agreed to pay $2.25 million to resolve allegations that it violated the Controlled Substances Act (CSA), DEA New Jersey Field Division Special Agent in Charge Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced today The manufacturer, Novel Laboratories Inc. (Novel), a subsidiary of...

Damian Williams, the United States Attorney for the Southern District of New York; Frank A. Tarentino III, the Special Agent in Charge of the New York Division of the Drug Enforcement Administration (“DEA”); and Darren B. McCormack, the Acting Special Agent in Charge of the New York Field Office of...

POCATELLO – Dr. Gerald Knouf, a family medicine doctor formerly of Pocatello, Idaho, agreed to pay $96,000 to resolve allegations that he wrote unlawful prescriptions, prescribed dangerous combinations of drugs, and billed Medicare and Medicaid for services that were not performed, U.S. Attorney Josh Hurwit announced today. The settlement also...

ALBUQUERQUE – Three of the eight defendants indicted following a joint enforcement operation last year in Carlsbad, pleaded guilty in federal court to federal drug offenses. Carlos Venegas, Jr., 24, of Carlsbad, pleaded guilty on March 4, 2024, to one count each of conspiracy to distribute 50 grams and more...

NEWARK, N.J. – The owner of a New Jersey company today admitted mislabeling hazardous chemicals entering the United States and evading customs duties, DEA New Jersey Field Division Special Agent in Charge Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced today. George Volpe, 60, of Roseland, New Jersey, owner...

WACO, Texas – Shrieve Chemical Company, LLC, a Drug Enforcement Administration-registered importer and distributor of listed chemicals, has agreed to pay $300,000 in civil penalties to resolve allegations that it violated provisions of the Controlled Substances Act, 21 U.S.C. §§ 801 et seq. In December 2022, DEA diversion investigators conducted...